title: Back to basics: PCSK9 as a new target for the LDL receptor.
authors.forename: Pablo
authors.initials: P
authors.lastname: Corral
mesh_terms: D050197:Atherosclerosis / Q000628:therapy*; D008078:Cholesterol, LDL / Q000378:metabolism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D026502:LDL-Receptor Related Proteins / Q000378:metabolism*; D011110:Polymorphism, Genetic; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use*; D012307:Risk Factors; D012697:Serine Endopeptidases / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D026502:LDL-Receptor Related Proteins; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases